Inventiva is a clinical-stage biopharmaceutical company headquartered in France, focused on lanifibranor in a Phase 3 trial, NATiV3, in MASH. This leadership role shapes North America regulatory strat...
Inventiva is a clinical-stage biopharmaceutical company headquartered in France, focused on lanifibranor in a Phase 3 trial, NATiV3, in MASH. This leadership role shapes North America regulatory strat...